ctrl K

Advertisement

Vigil Neuroscience Inc. (VIGL)

NASDAQ: VIGL · Real-Time Price · USD

1.88

0.06 (3.30%)

Apr 29, 2025, 1:17 PM - Market open

Vigil Neuroscience Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	399K	1.01M	345K	n/a
Gross Profit	n/a	-399K	-1.01M	-345K	n/a
Operating Income	-89.68M	-88.87M	-68.88M	-42.41M	-6.29M
Interest Income	n/a	n/a	623K	3K	n/a
Pretax Income	-84.26M	-82.64M	-68.31M	-43.28M	-28.55M
Net Income	-84.26M	-82.64M	-67.73M	-43.25M	-28.55M
Selling & General & Admin	27.38M	27.93M	21.44M	10.08M	1.78M
Research & Development	62.31M	60.93M	47.44M	32.33M	4.51M
Other Expenses	n/a	n/a	-44K	-877K	n/a
Operating Expenses	89.68M	88.87M	68.88M	42.41M	6.29M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	1.77M
Cost & Expenses	n/a	88.87M	68.88M	42.41M	6.29M
Income Tax Expense	n/a	n/a	-579K	-31K	-12.58K
Shares Outstanding (Basic)	40.67M	38.71M	31.69M	1.53M	28.26M
Shares Outstanding (Diluted)	40.67M	38.71M	31.69M	1.53M	28.26M
EPS (Basic)	-2.07	-2.13	-2.14	-28.24	-1.01
EPS (Diluted)	-2.07	-2.13	-2.14	-28.24	-1.01
EBITDA	-89.68M	-88.47M	-67.3M	-42.94M	-28.55M
EBIT	n/a	-88.87M	-68.88M	-42.41M	-12.58M
Depreciation & Amortization	n/a	399K	1.01M	345K	12.58M